Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rubicon Research Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013420
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti allergy, analgesics, metabolics and nutritional dietary supplements. It offers products in various formulations such as powders, granules, pellets, immediate release tablets, hard gelatin capsules, and others. Rubicon offers services such as pre-formulation, formulation development, analytical development, stability evaluations, regulatory affairs, registration, and others. The company’s proprietary technologies provide solutions for bioavailability enhancement, gastric retention, taste masking, and customising the release profiles. It also offers contract manufacturing and clinical trial supply services. Rubicon is headquartered in Mumbai, Maharashtra, India.

Rubicon Research Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Everstone Capital Management Acquires 70% stake in Rubicon Research for USD33 Million 10
Rubicon Research May Raise up to USD36 Million in Financing Round 11
Partnerships 12
Rubicon Research Enters Into Co-Development Agreement With Avantor 12
Rubicon Research Pvt Ltd – Key Competitors 13
Rubicon Research Pvt Ltd – Key Employees 14
Rubicon Research Pvt Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rubicon Research Pvt Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Rubicon Research Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Everstone Capital Management Acquires 70% stake in Rubicon Research for USD33 Million 10
Rubicon Research May Raise up to USD36 Million in Financing Round 11
Rubicon Research Enters Into Co-Development Agreement With Avantor 12
Rubicon Research Pvt Ltd, Key Competitors 13
Rubicon Research Pvt Ltd, Key Employees 14
Rubicon Research Pvt Ltd, Other Locations 15

★海外企業調査レポート[Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ICICI Bank Ltd:企業のM&A・事業提携・投資動向
    ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Hamamatsu Photonics KK (6965):企業の財務・戦略的SWOT分析
    Hamamatsu Photonics KK (6965) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • GS Energy Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary GS Energy Corp (GS Energy) is an energy holding company that manufactures and markets transportation fuels. The company's services include exploration and production, green growth, gas and electric power, refining and petrochemicals. It's refining and petrochemicals services comprise manufac …
  • Compania General de Combustibles SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania General de Combustibles SA (CGC), a subsidiary of Corporacion America Sudamericana SA is an oil and gas company that produces petroleum products. The company’s products include crude oil, liquefied petroleum gas, natural gas, gasoline and others. It offers services such as domestic …
  • Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrel …
  • GDS Holdings Ltd (GDS):企業の財務・戦略的SWOT分析
    GDS Holdings Ltd (GDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bridgford Foods Corporation:戦略・SWOT・企業財務分析
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Senvion SA:企業の戦略的SWOT分析
    Senvion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • H. Lundbeck AS (LUN):製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. Its products are indicate …
  • Banco Angolano de Investimentos, SA:企業の戦略・SWOT・財務情報
    Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report Summary Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Mitsubishi Tanabe Pharma Corp (4508):企業の財務・戦略的SWOT分析
    Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Siemens AG (SIE):電力:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • W. L. Gore & Associates Inc:企業の製品パイプライン分析
    Summary W. L. Gore & Associates Inc (Gore) is a materials science company serving diverse industries. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company develops products for medical implants; fabr …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Fagron NV (FAGR)-医療機器分野:企業M&A・提携分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a provider of pharmaceutical compounding solutions. The company provides compounding essentials, trademarks, and pharma services to pharmacies, hospitals and clinics. Its compounding services provide customized pharmaceutical products for specific pa …
  • Moser Baer India Ltd (MOSERBAER):企業の財務・戦略的SWOT分析
    Moser Baer India Ltd (MOSERBAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆